(E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid

C1=CC(=C(C=C1/C=C/C(=O)O)O)O

InChI=1S/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2+

QAIPRVGONGVQAS-DUXPYHPUSA-N

caffeic acid; 3,4-Dihydroxycinnamic acid; 331-39-5; trans-caffeic acid; 501-16-6; 3,4-Dihydroxybenzeneacrylic acid; 3-(3,4-dihydroxyphenyl)acrylic acid; (E)-3-(3,4-dihydroxyphenyl)acrylic acid; (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; Caffeicacid; Cinnamic acid, 3,4-dihydroxy-; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid; (E)-3,4-dihydroxycinnamic acid; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-; trans-Caffeate; 4-(2-Carboxyethenyl)-1,2-dihydroxybenzene; 3,4-Dihydroxy-trans-cinnamate; 3-(3,4-Dihydroxyphenyl)propenoic acid; 4-(2'-Carboxyvinyl)-1,2-dihydroxybenzene; NSC 57197; Caffeate; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (E)-; 3-(3,4-Dihydroxy phenyl)-2-propenoic acid; NSC-57197; 71693-97-5; CHEMBL145; NSC-623438; U2S3A33KVM; (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; AI3-63211; MLS000069738; CHEBI:16433; trans-3,4-Dihydroxycinnamic Acid; NSC57197; 331-89-5; SMR000058214; (2E)-3-(3,4-dihydroxyphenyl)acrylic acid; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (2E)-; MFCD00004392; Caffeic acid - Natural; CCRIS 847; 3-(3,4-dihydroxyphenyl)prop-2-enoic acid; HSDB 7088; SR-01000000203; EINECS 206-361-2; UNII-U2S3A33KVM; CHEBI:36281; caffeic-acid; Caffeic acid pure; Caffeic acid, 1; Caffeic acid 1000 microg/mL in Acetone; 3,4-dihydroxycinnamic acid (caffeic acid); Caffeic Acid,(S); Caffeic acid, trans-; 3,4-dihydroxycinnamate; CAFFEIC ACID natural; Opera_ID_1700; CAFFEIC ACID [MI]; CAFFEIC ACID [DSC]; Cinnamic acid,4-dihydroxy-; 3,4-Dihydroxycinnamic acid, predominantly trans; CAFFEIC ACID [HSDB]; CAFFEIC ACID [IARC]; CAFFEIC ACID [INCI]; 3,4-Dihydroxybenzeneacrylate; SCHEMBL23358; MLS001076493; MLS002207132; MLS002222302; MLS006011849; BIDD:ER0456; SPECTRUM1503987; CAFFEIC ACID [WHO-DD]; 2-Propenoic acid,3-(3,4-dihydroxyphenyl)-, (2E)-; 3,4-Dihydroxycinnamate, XVII; BDBM4375; cid_689043; GTPL5155; ZINC58172; AMY3943; DTXSID901316055; HMS2235G09; HMS3260J17; HMS3649O17; BCP28271; HY-N0172; Tox21_500208; BBL012113; Caffeic Acid - CAS 331-39-5; CCG-38895; NSC623438; s2277; STK397812; Caffeic acid, >=98.0% (HPLC); 2-Propenoic acid,4-dihydroxyphenyl)-; AKOS000144463; AC-8006; CS-8205; DB01880; LP00208; SDCCGMLS-0002982.P003; SDCCGSBI-0050196.P004; NCGC00017364-04; NCGC00017364-05; NCGC00017364-06; NCGC00017364-07; NCGC00017364-08; NCGC00017364-09; NCGC00017364-10; NCGC00017364-11; NCGC00017364-12; NCGC00017364-13; NCGC00017364-22; NCGC00022654-03; NCGC00022654-04; NCGC00022654-05; NCGC00022654-06; NCGC00022654-07; NCGC00022654-08; NCGC00022654-09; NCGC00260893-01; (E)-3-(3,4-dihydroxyphenyl)acrylicacid; AS-10895; BP-30112; SMR004703501; XC164210; Caffeic acid, purum, >=95.0% (HPLC); AB00490047; EU-0100208; SW197202-3; 2-Morpholin-4-yl-isonicotinicacidhydrochloride; (E)-3-(3,4-dihydroxyphenyl)prop-2-enoicacid; C 0625; C-1500; C01197; C01481; EN300-1067793; (2E)-3-(3,4-Dihydroxyphenyl)-2-propenoic acid; 331C395; A851723; Q414116; SR-01000000203-2; SR-01000000203-6; SR-01000000203-7; SR-01000000203-8; BRD-K09900591-001-06-9; SR-01000000203-13; CAFFEIC ACID (CONSTITUENT OF BLACK COHOSH) [DSC]; F3096-1708; Z240113804; 8B3E4DA7-F3B0-4972-A315-2E387071737F; trans-Caffeic acid, certified reference material, TraceCERT(R); Caffeic acid, matrix substance for MALDI-MS, >=99.0% (HPLC); Caffeic acid, United States Pharmacopeia (USP) Reference Standard; Caffeic acid, matrix substance for MALDI-MS, >=99.0% (HPLC), powder, light beige